Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 9
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
MSI-H / dMMR
gastric cancer · Combination Therapy
MSI-H / dMMR is flagged as manual review required because public trials show inclusion required evidence in 15 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 25
Common snippets: dMMR | dMMR | dMMR
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT07658872 | https://clinicaltrials.gov/study/NCT06426654 | https://clinicaltrials.gov/study/NCT05769725 | https://clinicaltrials.gov/study/NCT04603040 | https://clinicaltrials.gov/study/NCT07266025 | https://clinicaltrials.gov/study/NCT05836584 | https://clinicaltrials.gov/study/NCT05177133 | https://clinicaltrials.gov/study/NCT04152889 | https://clinicaltrials.gov/study/NCT06974110 | https://clinicaltrials.gov/study/NCT07692204 | https://clinicaltrials.gov/study/NCT06250036 | https://clinicaltrials.gov/study/NCT05002686 | https://clinicaltrials.gov/study/NCT05713838 | https://clinicaltrials.gov/study/NCT03935893 | https://clinicaltrials.gov/study/NCT04221555